FR3101542B1 - USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT - Google Patents

USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT Download PDF

Info

Publication number
FR3101542B1
FR3101542B1 FR1910995A FR1910995A FR3101542B1 FR 3101542 B1 FR3101542 B1 FR 3101542B1 FR 1910995 A FR1910995 A FR 1910995A FR 1910995 A FR1910995 A FR 1910995A FR 3101542 B1 FR3101542 B1 FR 3101542B1
Authority
FR
France
Prior art keywords
plant cells
alpinum
cosmetic treatment
leontodium
antiglycation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1910995A
Other languages
French (fr)
Other versions
FR3101542A1 (en
Inventor
Philippe Mondon
Nathalie Rouyer
Laure Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR1910995A priority Critical patent/FR3101542B1/en
Priority to CN202080069753.1A priority patent/CN114502140A/en
Priority to PCT/EP2020/077659 priority patent/WO2021064173A1/en
Priority to EP20785974.5A priority patent/EP4037656A1/en
Publication of FR3101542A1 publication Critical patent/FR3101542A1/en
Application granted granted Critical
Publication of FR3101542B1 publication Critical patent/FR3101542B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Selon l’invention, il est proposé l’utilisation de cellules végétales indifférenciées ou dédifférenciées de Leontopodium alpinum obtenues par culture cellulaire in vitro, pour un traitement cosmétique non thérapeutique pour prévenir la glycation de macro-molécules de la peau, notamment les protéines, les acides nucléiques et/ou les lipides.According to the invention, there is proposed the use of undifferentiated or dedifferentiated plant cells of Leontopodium alpinum obtained by cell culture in vitro, for a non-therapeutic cosmetic treatment to prevent the glycation of macro-molecules of the skin, in particular proteins, nucleic acids and/or lipids.

FR1910995A 2019-10-04 2019-10-04 USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT Active FR3101542B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1910995A FR3101542B1 (en) 2019-10-04 2019-10-04 USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT
CN202080069753.1A CN114502140A (en) 2019-10-04 2020-10-02 Anti-aging cosmetic treatment for anti-saccharification effect of alpine edelweiss plant cells
PCT/EP2020/077659 WO2021064173A1 (en) 2019-10-04 2020-10-02 Use of leontodium alpinum plant cells for an anti-glycation anti-ageing skin treatment
EP20785974.5A EP4037656A1 (en) 2019-10-04 2020-10-02 Use of leontodium alpinum plant cells for an anti-glycation anti-ageing skin treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1910995 2019-10-04
FR1910995A FR3101542B1 (en) 2019-10-04 2019-10-04 USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT

Publications (2)

Publication Number Publication Date
FR3101542A1 FR3101542A1 (en) 2021-04-09
FR3101542B1 true FR3101542B1 (en) 2022-10-28

Family

ID=69158061

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1910995A Active FR3101542B1 (en) 2019-10-04 2019-10-04 USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT

Country Status (4)

Country Link
EP (1) EP4037656A1 (en)
CN (1) CN114502140A (en)
FR (1) FR3101542B1 (en)
WO (1) WO2021064173A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802769B1 (en) * 1999-12-23 2004-01-16 Oreal LEONTOPODIUM GENE PLANT EXTRACT AND COMPOSITIONS CONTAINING THE SAME
FR2821086B1 (en) 2001-02-21 2003-12-12 Sederma Sa PROCESS FOR THE MANUFACTURE OF PROTEINS BY FERMENTATION OF MICROORGANISMS OF THE THERMUS FAMILY, MIXTURE OF PROTEINS THUS OBTAINED AND COSMETIC COMPOSITION CONTAINING THEM
FR2836042B1 (en) 2002-02-15 2004-04-02 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING POCKETS AND DARK CIRCLES UNDER EYES
FR2927801B1 (en) 2008-02-22 2010-03-05 Sederma Sa MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARIN AND ERYTHRITOL
EP2319914A1 (en) 2009-11-09 2011-05-11 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Preparation and use of plant meristem cells with a high content of caffeic acid derivatives
FR2980362B1 (en) 2011-09-27 2013-10-04 Sederma Sa NOVEL COSMETIC USE OF ALBIZIA JULIBRISSIN EXTRACT AND CORRESPONDING TOPICAL COMPOSITION
EP2623094A1 (en) * 2012-02-02 2013-08-07 DSM IP Assets B.V. Use of an edelweiss extract
FR2998570B1 (en) 2012-11-26 2016-12-02 Sederma Sa PEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND PARTICULARLY COSMETIC USES THEREOF
FR3021319B1 (en) 2014-05-22 2018-08-31 Sederma PEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND PARTICULARLY COSMETIC USES
KR101740097B1 (en) * 2014-10-13 2017-05-29 주식회사 바이오에프디엔씨 Anti-inflammation and Anti-aging composition for skin external application comprising Leontopodium alpinum Cell Culture Extract and Methods for preparing the Same
FR3029782B1 (en) 2014-12-16 2019-06-07 Sederma PEPTIDE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES IN PARTICULAR COSMETICS
FR3031454B1 (en) * 2015-01-13 2018-05-11 Sederma USE OF LEONTOPODIUM ALPINUM VEGETABLE CELLS FOR COSMETIC TREATMENT AND CORRESPONDING ACTIVE COSMETIC INGREDIENT
FR3052453B1 (en) 2016-06-14 2018-05-18 Sederma PEPTIDE, COMPOSITION COMPRISING SAME AND USES IN PARTICULAR COSMETICS

Also Published As

Publication number Publication date
FR3101542A1 (en) 2021-04-09
WO2021064173A1 (en) 2021-04-08
CN114502140A (en) 2022-05-13
EP4037656A1 (en) 2022-08-10

Similar Documents

Publication Publication Date Title
Rahmani et al. Immune modulation of hair follicle regeneration
Gaur et al. Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging
Maan et al. Cell recruitment by amnion chorion grafts promotes neovascularization
Guo et al. Comparison of odontogenic differentiation of human dental follicle cells and human dental papilla cells
Clark et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome
Ito et al. Low-intensity pulsed ultrasound inhibits messenger RNA expression of matrix metalloproteinase-13 induced by interleukin-1β in chondrocytes in an intensity-dependent manner
WO2007052980A1 (en) Collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system
Balzano et al. Lessons from human umbilical cord: Gender differences in stem cells from Wharton’s jelly
TR201913215A2 (en) USE OF HERBAL EXOSOMES TO INCREASE THE VITALITY OF SKIN CELLS AND THEIR HAIR REMOVAL CAPACITY
Pan et al. Conditioned medium derived from human amniotic stem cells delays H2O2‑induced premature senescence in human dermal fibroblasts
Madonna et al. Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells
DE60140051D1 (en) HUMAN GROWTH HORMON FOR STIMULATING THE MOBILIZATION OF PLURIPOTENTAL HEMAPOIETIC STEM CELLS
FR3101542B1 (en) USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTIGLYCATION COSMETIC TREATMENT
Putra et al. Topical gel of mesenchymal stem cells-conditioned medium under TNF-α precondition accelerates wound closure healing in full-thickness skin defect animal model
WO2018080148A3 (en) Three-dimensional cell culture system comprising peg-based hydrogel
WO2011116361A1 (en) Compositions and manufacture of mammalian stem cell-based cosmetics
Chang et al. Amniotic fluid stem cells with low γ-interferon response showed behavioral improvement in parkinsonism rat model
WO2020185056A3 (en) Method for culturing allogeneic immune cell, immune cell culture obtained thereby, and immune cell therapeutic agent comprising same
KR20130009117A (en) Composition for hair growth promotion ingredient in stem cell culture medium
FR3092759B1 (en) ACTIVE TO EMOGENIZE THE COMPLEXION, ESPECIALLY FOR SKIN WITH OLIVE CARNATION
Fridman et al. Comparison of the effects of KE and AED peptides on functional activity of human skin fibroblasts during their replicative aging
JP2017529066A5 (en)
Guo et al. Effects of mechanical stimulus on mesenchymal stem cells differentiation toward cardiomyocytes
CN113980896A (en) Application of IRF1 in regulating and controlling immune regulation effect of mesenchymal stem cells and product
Chistiakova et al. Influence of human fetal mesenchymal stem cells on glioma cell proliferation. A consequence of cellular crosstalk

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210409

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5